4//SEC Filing
Margrave David R. 4
Accession 0001493152-24-028186
CIK 0001763950other
Filed
Jul 16, 8:00 PM ET
Accepted
Jul 17, 4:30 PM ET
Size
5.5 KB
Accession
0001493152-24-028186
Insider Transaction Report
Form 4
Margrave David R.
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-07-15+52,000→ 52,000 totalExercise: $4.35Exp: 2034-07-15→ Common Stock (52,000 underlying)
Footnotes (1)
- [F1]The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Stock Incentive Plan. The Options shall vest and first become exercisable in equal monthly increments over a 24-month period commencing August 15, 2024.
Documents
Issuer
Lantern Pharma Inc.
CIK 0001763950
Entity typeother
Related Parties
1- filerCIK 0001813162
Filing Metadata
- Form type
- 4
- Filed
- Jul 16, 8:00 PM ET
- Accepted
- Jul 17, 4:30 PM ET
- Size
- 5.5 KB